欧洲PMC在2023年
Summer Rosonovski1, Maria Levchenko1, Rajat Bhatnagar1
1Literature Services, EMBL-EBI, Wellcome Trust Genome Campus, Cambridge, UK.
Nucleic acids research
|November 23, 2023
概括
欧洲PMC增强了其生命科学开放访问数据库,改善了预印发的可发现性,文本和数据挖掘支持,以及新的用户通知工具. 这些更新旨在提高研究的可复制性和可访问性.
科学领域:
- 生命科学 生命科学
- 生物信息学是一种生物信息学.
- 学术传播学术交流
背景情况:
- 欧洲PMC是一个主要的生命科学文献开放访问数据库.
- 该平台提供超过4200万篇摘要和900万篇全文文章的访问权限.
- 之前的平台开发最后一次更新是在2020年.
研究的目的:
- 概述自2020年以来欧洲PMC平台的最新进展.
- 详细介绍预印处理,文本和数据挖掘能力以及用户服务的改进.
- 将欧洲PMC定位为一个可持续,可访问和开放的学术基础设施.
主要方法:
- 索引新的预版内容和丰富元数据.
- 扩大注释类型和开发欧洲PMC注释库用于机器学习.
- 实施文章状态监控工具和电子邮件警报.
- 增加开源软件组件,提高服务的可持续性.
主要成果:
- 通过增强的索引和元数据,提高了预版的可发现性,可复制性和信任性.
- 增强了对文本和数据挖掘的支持,并扩展了注释和专门的语料库.
- 用户可以使用新的工具来监控文章并接收更新.
- 向更开放,更可持续和更容易获得的学术基础设施取得进展.
结论:
- 最近的发展显著提高了欧洲PMC平台对研究人员的实用性.
- 这些更新加强了欧洲PMC在支持开放科学和可重复研究方面的作用.
- 该平台可以更好地满足生命科学社区不断变化的需求.
更多相关视频
06:022-Methacryloyloxyethyl Phosphorylcholine Polymer Treatment of Complete Dentures to Inhibit Denture Plaque Deposition
Published on: December 26, 2016
10.4K
08:59Measuring Sub-23 Nanometer Real Driving Particle Number Emissions Using the Portable DownToTen Sampling System
Published on: May 22, 2020
5.5K
相关概念视频
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
